Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Return on Capital Employed (2016 - 2025)

Regenxbio (RGNX) has 11 years of Return on Capital Employed data on record, last reported at 0.43% in Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 16.0% year-over-year to 0.43%; the TTM value through Dec 2025 reached 0.43%, up 16.0%, while the annual FY2025 figure was 0.47%, 9.0% up from the prior year.
  • Return on Capital Employed reached 0.43% in Q4 2025 per RGNX's latest filing, down from 0.36% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.19% in Q4 2021 and bottomed at 0.6% in Q4 2024.
  • Average Return on Capital Employed over 5 years is 0.2%, with a median of 0.14% recorded in 2021.
  • Peak YoY movement for Return on Capital Employed: crashed -63bps in 2023, then surged 42bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.19% in 2021, then crashed by -287bps to 0.36% in 2022, then surged by 68bps to 0.12% in 2023, then tumbled by -413bps to 0.6% in 2024, then grew by 28bps to 0.43% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.43% in Q4 2025, 0.36% in Q3 2025, and 0.4% in Q2 2025.